The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so part of the problem is that the amyloid gets cleaved at a length of 40 or 42 amino acids rather than whatever it's supposed to be which i don't remember and then the abnormal amyloid kind of folds and you know there's fibrils and there's pla you know the plaque itself is a conglomeration of a series of folds in the protein
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
and the abnormal amyloid kind of folds and you know there's fibrils and there there's pla you know the plaque itself is a conglomeration of um a series of folds in the protein